Adjunctive hemoperfusion with Resin Hemoadsorption (HA) 330 cartridges improves outcomes in patients sustaining multiple Blunt Trauma: a prospective, quasi-experimental study

Table 3 Comparison of clinical variables before and after intervention between groups

Variables	Group	Before intervention	After intervention	Delta*	P-value
SBP (Mean, SD)	Control	110.84 (17.52)	111.84 (24.19)	1 (28.85)	0.36
SBP (Mean, SD)	Case	114.83(11.07)	124.58 (17.69)	9.75 (16.57)	0.36
DBP (Mean, SD)	Control	67.84 (14.77)	66.07 (9.97)	-1.77 (14.69)	0.45
DBP (Mean, SD)	Case	70.75 (6.35)	74.16 (17.98)	3.41 (19.32)	0.45
HR (Median, IQR)	Control	82 (75–112)	90 (75–100)	2 (-6–9)	0.82
HR (Median, IQR)	Case	99 (75 − 11)	89 (79–109)	1(-19–14.5)	0.82
RR (Median, IQR)	Control	20 (16–20)	16 (14–20)	0 (-5–4)	0.54
RR (Median, IQR)	Case	18 (17–21)	19 (16–21)	-2 (-2–0.5)	0.54
SI (Mean, SD)	Control	0.88 (0.48)	0.80 (0.17)	-0.08 (0.44)	0.96
SI (Mean, SD)	Case	0.83 (0.20)	0.76 (0.26)	-0.07 (0.22)	0.96
MAP (Mean, SD)	Control	82.17 (14.46)	81.33 (12.95)	-0.84 (15.89)	0.35
MAP (Mean, SD)	Case	85.44 (7.27)	90.97 (17.16)	5.53 (17.65)	0.35
PaO2/FIO2 (Mean, SD)	Control	304.90 (137.97)	300.57 (143.84)	-4.33 (217.60)	0.019 ^a
PaO2/FIO2 (Mean, SD)	Case	198.45 (111.79)	394.50 (149.67)	196.04 (173.27)	0.019 ^a
NLR (Median, IQR)	Control	5.64 (3.72–11.99)	4.90 (4.20–6.10)	-1.28 (-5.18–0.48)	0.88
NLR (Median, IQR)	Case	11.16 (6.24–17.67)	7.39 (3.23–15.48)	-3.64 (-6.28–2.56)	0.88

SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; HR, Heart Rate; RR, Respiratory Rate; SI, Shock Index; MAP; Mean Arterial Pressure; NLR, neutrophil to Lymphocyte Ration; SD, Standard Deviation; IQR, Inter-Quartile Range; NLR, Neutrophil/Lymphocyte Ratio
* The changes between the values of before and after intervention
^a Statistically Significant

ISSN: 1471-2482